Hemodynamic state was primarily assessed by mixed venous oxygen saturation (SvO 2 ).
ABSTRACT

INTRODUCTION
Postoperative heart failure is a major cause of in-hospital mortality after coronary artery bypass grafting (CABG) and frequently precipitated by myocardial ischemia and infarction (1) (2) (3) . Treatment of postoperative heart failure presents a therapeutic dilemma as inotropic agents not only aggravate ischemia and increase the size of evolving myocardial infarction, but also stimulate apoptotic processes that may have adverse long-term consequences (4, 5) . Thus, restrictive use of inotropes would be particularly desirable in patients with limited cardiac reserve. On the other hand, patients with preoperatively compromised left ventricular function are particularly prone to require treatment for postoperative cardiac failure (6, 7) . Accordingly, postoperative morbidity and mortality is more frequently encountered in patients with preoperatively compromised left ventricular function . Furthermore, long-term survival is markedly impaired (8, 9, 12, 14-17, 19, 26, 27, 29-39) .
In an effort to reduce postoperative work-load on the myocardium and facilitate myocardial recovery we evolved a metabolic strategy for perioperative care and have previously reported encouraging results in treatment of severe heart failure at weaning from CPB (40) . Here we report our short-term and long-term clinical experience in patients with preoperatively compromised left ventricular function undergoing CABG. An over-view of the literature with regard to short-term and long-term results is also given. Based on our results and the overview we will provide an argument for the principles of our strategy and the need for adequately powered randomized clinical trials to determine the role of metabolic interventions in cardiac surgery.
METHODS
Patients
During a five-year period (1991) (1992) (1993) (1994) (1995) when the metabolic strategy was introduced 775 consecutive patients operated for ischemic heart disease by two surgeons (RS, IV) were registered in a database. Left ventricular function was assessed by angiography or echocardiography. 104 patients presented with severely compromised left ventricular function (LVEF ) before surgery. The records of the patients were investigated in detail according to a protocol and data retrieved and stored in a database. Data on late mortality were retrieved from the Swedish Civil Registry. Follow-up was 100% complete and averaged 9.7±1.4 years. Demographic and intraoperative data are presented in table 2.
Clinical management
On the day of surgery all patients were given their individual doses of betablockers and calcium-antagonists. After premedication with morphine hydrochloride and scopolamine, anesthesia was induced with thiopentone and fentanyl, and maintained with fentanyl and isoflurane. Pancuronium bromide was used for neuromuscular blockade. Cardiopulmonary bypass (CPB) was conducted with a membrane oxygenator and a roller pump generating nonpulsatile flow. Ringer's acetate and mannitol were used for priming the extracorporeal circuit.
Moderate hemodilution (hematocrit 20 -25%) and mild to moderate hypothermia (32-35 °C)
were employed. Antegrade or combined antegrade and retrograde delivery of St. Thomas' cold crystalloid cardioplegic solution was used for myocardial protection. CPB was prolonged until recovery of left ventricular function was evident. Heparin was neutralized with protamine chloride. In the postoperative period rewarming was facilitated by radiant heat provided by thermal ceiling. Shed mediastinal blood was routinely retransfused after surgery.
Ringer's acetate was used for volume substitution.
Definitions
Use of inotropes was defined as a continuous infusion of beta-receptor stimulants or a bolus or continuous infusion of phosphodiesterase inhibitors regardless of dose. Dosage presented was calculated as the average dose per hour during the first 6 hours from weaning or from 6 -24 hours after weaning if the dose had been increased.
Complications presented refer to in-hospital events occurring at our institution. Intraoperative myocardial infarction was diagnosed by biochemical markers of myocardial injury or by findings at autopsy as previously reported (2, 41) .
Postoperative renal failure is presented according to STS data base definition and furthermore the proportion of patients having an increase of s-creatinine of 50% or more compared to preoperative value is given (42) .
Neurological injury in this study included the following cerebral complications: 1) stroke 2) depression of consciousness or confusion if associated with signs of cerebral injury on CTscan or focal neurological deficit 3) transient ischemic attacks with focal neurological deficit.
The majority of patients with suspected neurological injury were examined by a neurologist and by CT-scan. Cognitive dysfunction was not assessed.
Monitoring
Arterial, central venous and pulmonary artery pressures were monitored in all patients as well as ECG with ST-segment analysis. Pulmonary artery pressure and intermittent blood sampling for analysis of mixed venous oxygen saturation (SvO 2 ) was retrieved by either a Swan-Ganz catheter or an epidural catheter introduced during surgery through the right ventricular outflow tract into the pulmonary artery. Transesophageal echocardiography was employed in the majority of patients. SvO 2 and urinary output served as the main guidelines for hemodynamic therapy.
Metabolic strategy
A variety of methods to protect the heart are available and complex procedures can be safely performed. However, efforts have mainly focused on myocardial preservation during the period of aortic cross clamping. Preoperative and postoperative ischemia remain major risk factors for perioperative myocardial infarction (3, 43) . The metabolic strategy was evolved with the aim to reduce the consequences of myocardial ischemia during all phases of surgery and to facilitate metabolic and functional myocardial recovery after surgery (40, 44) .
The metabolic strategy implied adherence to physiological principles to minimize myocardial and systemic oxygen expenditure and specific measures such as extended CPB and metabolic support to facilitate myocardial recovery in patients with inadequate hemodynamic state.
Volume work by the heart rather than pressure work was promoted by after-load reduction when feasible. 
Metabolic support
During the time frame of the study availability of glutamate solutions was restricted due to limited capacity of the local pharmacy to produce solutions. Hence, prophylactic glutamate infusion was reserved for patients with signs of severe myocardial ischemia or heart failure in the operating room before surgery. In these patients glutamate was infused intravenously preoperatively and after release of cross clamp to prevent heart failure at weaning from CPB.
Intravenous glutamate was also instituted as treatment in patients with failure to wean from CPB at the first attempt.
High dose glucose-insulin-potassium (GIK) was added to intravenous glutamate infusion in patients with failure to wean from CPB at the first attempt. Details of treatment with intravenous glutamate and high-dose GIK have been reported previously (40, 46) . Safety issues with regard to the metabolic treatments have been addressed (46, 47) .
Statistics
The results are presented as percentages or mean ± standard deviation. 
RESULTS
Demographics
The mean age was 65 ± 9 years, 20.2% of the patients had diabetes mellitus, 29.8% unstable angina. The mean left ventricular ejection fraction was 0.30 ± 0.05 (range 0.20-0.37). An average of 3.5 ± 1.3 vessels were bypassed and 6.7% of the patients also had a concomitant valve procedure. One third of the procedures were performed urgently or emergently.
Demographic and intraoperative data are given in table 2.
Outcome
Postoperative data are given in Ten-year survival according to Kaplan-Meier is presented in figure 1 . 
Metabolic support
Glutamate was initiated in 24.0% of the patients to prevent heart failure and in 15.4% for treatment of heart failure at weaning from CPB. 67% of the patients treated with glutamate also received high-dose GIK. Patients treated with glutamate had an average LVEF of 0.27 ± 0.05. Logistic EuroSCORE was 15.1% whereas observed 30-day mortality was 2.4%. Fiveyear survival in patients treated with glutamate was 82.9%.
High-dose GIK was used in 27.9% of the cases for treatment of heart failure at weaning from CPB. No side effects of the infusions were observed. 93% of these patients also received glutamate infusion. Patients treated with high-dose GIK had an average LVEF of 0.26 ± 0.05.
Logistic EuroSCORE was 17.4% whereas observed 30-day mortality was 3.4%. Five-year survival in patients treated with high-dose GIK was 82.8%.
Use of intravenous glutamate increased from 28.6% during the first half to 43.4% during the second half of the period studied (p=0.18) and corresponding figures for high-dose GIK was 10.7% v 34.7% (p=0.025). Overall intravenous metabolic support was given to 41.3% of the patients (table 3) .
Pharmacological circulatory support
Use of inotropes for weaning decreased from 17.9% during the first half to 2.6% during the second half of the period studied (p=0.015). Patients treated with inotropes for weaning from CPB had an average LVEF of 0.30 ± 0.04. Logistic EuroSCORE was 19.0% whereas observed 30-day mortality was 14.3%. Five-year survival in patients treated with inotropes was 53.9%.
In the ICU low dose inotropes or phosphodiesterase inhibitors were used to enhance urinary output in a total of 37.3% of the patients. The average doses when used were for dobutamine 2.2 1.1 g/kg and min (n=30), dopamine 1.6 1.1 g/kg and min (n=6) and for epinephrine 28 27 ng/kg and min (n=5).
Overall nitroprusside was used in 53.8% of the patients and vasoconstrictors in 21.4%. Of the patients that received high-dose GIK 51.7% required angiotensin or norepinephrine to counteract vasodilatation.
Mechanical circulatory support
Extended reperfusion time on CPB to allow the heart to recover was a key issue in the strategy. In patients that could be weaned at the first attempt CPB time and aortic cross clamp time were 81 ± 27 minutes and 40 ± 19 minutes respectively. In patients with difficulty to wean at the first attempt (n=32) CPB time averaged 127 ± 62 minutes while cross clamp time was 45 ± 28 minutes. 94% of the patients with initial weaning difficulties were treated with metabolic support and 78% could be weaned from CPB without inotropes.
Mechanical circulatory support with intra-aortic balloon pump or Hemopump ® was used in 1.9% of the cases (table 3) . Of the patients with initial weaning difficulties 6.3% required mechanical circulatory support with intraaortic balloon pump or hemopump.
Outcome related to mixed venous oxygen saturation
Mixed venous oxygen saturation was obtained on arrival to ICU in 101 patients. The majority (n=94) had SvO 2 ≥ 55% and in these patients postoperative morbidity and mortality was negligible compared with those having SvO 2 < 55% (table 4) .
In patients (n=68) who arrived to ICU with SvO 2 ≥ 55% and without history of weaning problems no one developed renal failure, 30-day mortality was zero and five-year survival was 95.6%.
COMMENT
The metabolic strategy was associated with lower 30-day mortality (1.0%) than previously reported in patients with severe LV-dysfunction undergoing CABG (table 5) . It was also substantially lower than the expected risk adjusted mortality of 8.3% according to logistic
EuroSCORE. Long-term survival was an even more encouraging with a crude 5-year survival of 89.4%.
It is generally accepted that case selection is vital for outcome in patients with poor LVfunction undergoing CABG and reviewing the literature one should first appreciate the inherent publication bias present both from authors and journals. Poor or even average results are less likely to be published. Typically the published papers differ from the STS data base from the corresponding time reporting a substantially higher mortality of 7.6% in patients with EF≤0.35 (48) . Furthermore, the majority of studies are highly selected case series excluding patients that required valve procedures, redo-procedures, patients with cardiogenic shock and occasionally only including those that hade viable myocardium detected preoperatively or even excluding those that required IABP, had recent preoperative events or died early after surgery. Follow-up is not always complete and the proportion of patients with poor LV-function in relation to total cohort is strikingly high in several series (table 5) . The results of the metabolic strategy compare favorably with the literature particularly considering these circumstances. It is also generally accepted that most centers report better than expected mortalities according to EuroSCORE, however, rarely a fraction below 0.2.
The major limitation of this study is that it, like most studies on this high risk group, is retrospective and observational. However, it is one of few studies to address this category of patients from a perspective of perioperative management and it rises important questions that deserve to be addressed in future studies.
Minimizing myocardial metabolic demands -avoiding inotropes
Postoperative heart failure after CABG is frequently precipitated by myocardial ischemia and infarction(2, 3). As inotropic agents cause an excessive increase in myocardial oxygen expenditure in relation to the hemodynamic effect achieved it is not surprising that they aggravate ischemia and increase the size of evolving myocardial infarction (4, 49) . A high incidence of myocardial ischemia and myocardial infarction has been reported in humans when inotropes are used to terminate cardiopulmonary bypass (50, 51) . Furthermore, it has recently been shown that also the rate of apoptosis is markedly increased by adrenergic stimulation, which could affect long-term outcome adversely(5, 52).
Alternative measures that can enhance myocardial recovery and function without putting further strain on the heart are particularly desirable in patients with limited myocardial reserve. Our experience demonstrates that traditional pharmacological inotropic support for weaning from cardiopulmonary bypass can be replaced by alternative measures even in patients with severely compromised left ventricular function without jeopardizing renal function. As the confidence in the metabolic strategy grew the use of inotropes for weaning from CPB during the latter half of the studied period was reduced to 2.6%. The average doses of inotropes when used were low ( however, evident from the debate on aprotinin that it may be difficult to detect a negative effect of a drug on survival on an individual physician basis and even on an institutional basis (55) . Therefore, the words of Yusuf et al that it is essential to exclude a negative effect on long-term survival of beta-stimulators and phospdiesteraseinhibitors before they are incorporated into routine clinical practice deserve to be echoed (56) .
Metabolic support
The rationale for intravenous glutamate infusion and high-dose glucose-insulin-potassium (GIK) has been described previously (40) . Intravenous glutamate infusion was used both to prevent postoperative heart failure and for treatment of postoperative heart failure. Because of the potent vasodilatory effects and the need for careful monitoring of blood glucose and electrolytes high-dose GIK was reserved for treatment of postoperative heart failure (46).
The present data do not permit any inference regarding functional or metabolic recovery.
However, we and other have previously shown that both glucose-insulin-potassium (GIK) and glutamate can enhance the metabolic and functional recovery of the postischemic heart (40, 49, (57) (58) (59) (60) (61) (62) (63) . In contrast to inotropes the improvement in hemodynamic state is achieved without undue increase in myocardial oxygen demand. Also, insulin is a powerful antiapoptotic agent in contrast to adrenergic drug (64) .
Both glutamate and high-dose GIK treatment was associated with substantially lower mortality than predicted by EuroSCORE. Although EuroSCORE underestimates mortality in general this may not be the fact in high risk patients as was illustrated by a recent conference report on levosimendan given prophylactically in high-risk patients and for treatment of postoperative heart failure(65).
Unloading of the heart -Extended CPB
Premature use of inotropic drugs for weaning from cardiopulmonary bypass has been shown to impede metabolic and functional recovery of the heart in animals(66).
Some degree of extended CPB was employed in virtually all patients and CPB was substantially extended in patients with weaning difficulty with an average reperfusion time of approximately 80 minutes to permit myocardial recovery during metabolic support. The potential adverse effects of CPB are well known and short perfusion times and even avoidance of CPB are advocated by many surgeons. However, our results suggest that under certain circumstances the benefits of unloading the heart may outweigh the drawbacks of CPB. These results are in agreement with Royster et al who found that long pump times were associated with lower need for inotropes after coronary surgery on patients with LVEF ≤ 0.45 (6) .
We acknowledge that liberal use of IABP may be a useful strategy to preserve myocardium in critically ill patients. Dietl et al reported a substantially lower operative mortality compared to historic controls when liberal use of preoperative IABP was adopted in patients with severe LV-dysfunction(28). Although we preferred an IABP in favor of increasing the dose of inotropic drugs such as dobutamine above 5 /kg/min the need for IABP was low with the metabolic strategy.
Pharmacological after-load reduction played an essential role in the metabolic strategy which is illustrated by the frequent use of nitroprusside and furthermore, high-dose GIK provides a powerful and protracted vasodilation. Inodilators were used sparsely because of a reluctance to combine these drugs with high-dose GIK.
Monitoring
It is essential that hemodynamic variables monitored correlate with clinical outcome. The treatment targets for cardiac output have not been scientifically validated but it appears that many centers aim for a cardiac index exceeding 2.3 or 2.5 L/min(50). In our opinion this will lead to overuse of inotropes as we have previously found that anesthetized low risk patients undergoing CABG with uneventful postoperative course had an average cardiac index of 2.1 L/min with SvO2 exceeding 70% and excellent recovery of myocardial metabolism (67) . In contrast, we have reported that if patients treated according to the metabolic strategy arrived in ICU without inotropes and SvO 2 exceeding 55% the risk of subsequent circulatory problems requiring ICU stay > 2 days because of cardiorespiratory morbidity was 1.1% (45) .
The results of the present study demonstrate that these findings are valid also for patients with preoperatively compromised LV-function. However, we emphasize that SvO 2 is evaluated in conjunction with other hemodynamic data and hemodynamic targets tailored after the individual patients (table 1) .
Later in the postoperative course it is conceivable that adrenergic stimulation is less detrimental as the myocardium has been provided time to recover from the ischemic insult sustained during surgery. Hence, inotropes were used in low doses in the ICU to promote urinary output in just over one third of the patients overall and two thirds of those that presented with weaning problems.
It can be argued that a strategy that accepts low cardiac outputs could jeopardize perfusion of vital organs. Renal function is a sensitive marker of the adequacy of hemodynamic treatment.
This report and previous experience shows that patients with compromised ventricular function and even overt postoperative heart failure can be treated with a low incidence of renal complications (40) . In this study an increase of s-creatinine by 50% or more compared to preoperative values was found in 2.9 % of the cases, which is substantially lower than the 16% overall incidence (same definition) after CABG surgery reported from a comparable Scandinavian Center (42) . In the latter study multivariable analysis identified the use of adrenergic drugs as an important determinant for development of postoperative renal failure (42) .
If adrenergic drugs are used in high doses, vasoconstrictive properties will be more pronounced and renal perfusion may be jeopardized. In contrast, there is evidence, albeit limited, that GIK and amino acid infusion may enhance renal perfusion (68) . Also, potential delay of recovery at cellular level or aggravation of evolving myocardial infarction by inotropic stimulation could lead to more severe and prolonged states of low output syndrome.
The metabolic strategy comprises a multimodal approach and although it is difficult to discern the relative importance of each issue from the present study all major aspects have been addressed separately by our group and others. To fully elucidate the clinical role of metabolic support adequately powered randomized trials are necessary and desirable. On the other hand, from other areas of surgical research it has been argued that it may be difficult to improve clinical outcome with single measures and that a multimodal approach might be necessary to achieve such aims (69) .
To conclude our initial five-year experience with the metabolic strategy in patients with preoperatively compromised left ventricular function was associated with encouraging results.
The metabolic strategy allowed restrictive use of inotropes and was associated with short-term and long-term survival that compares favorably with the literature and that was substantially better than risk-adjusted expected mortality in this high-risk cohort. Renal function was well preserved suggesting that mixed venous oxygen saturation and urinary output served as adequate markers of hemodynamic state. Randomized trials with glutamate and high-dose GIK are warranted to elucidate their role in the treatment of high risk patients undergoing surgery for ischemic heart disease. Table 2 . Preoperative and intraoperative data given as percentages and numbers of total within brackets or mean ± standard deviation. AMI = acute myocardial infarction. LVEF = left ventricular ejection fraction. COPD = chronic obstructive pulmonary disease. NYHA = New York Heart Association. Urgent procedure = urgent surgery required but scheduled within a few days. Emergency procedure = surgery within 24 hours. CI = confidence interval. LITA = left internal thoracic artery.
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